INTRODUCTION: To determine the safety and efficacy of single-site robotic cholecystectomy compared to multi-port laparoscopic cholecystectomy within a high-volume tertiary health care center.
METHODS AND PROCEDURES: A retrospective analysis of prospectively maintained data was conducted on patients undergoing single-site robotic cholecystectomy or multi-port laparoscopic cholecystectomy between October 2011 and July 2014. All surgeries included in the study were performed by a single surgeon. P
INTRODUCTION: Pneumatic balloon dilation (PBD) has been preferred as the primary treatment for esophageal achalasia since it is relatively easy to perform, generally requires no hospital stay, and is cost-efficient in short-term. However, laparoscopic cardiomyotomy is eventually required in refractory cases as a definitive treatment after failed PBD. The forceful tear of lower esophageal sphincter (LES) during PBD potentially causes post-procedural reactive fibrosis around LES, and controversy h
Introduction: The effects of hospital volume on in-hospital mortality after esophageal resection are disputed in literature. We sought to analyze treatment effects in patient subpopulations that undergo esophagectomy for cancer based on hospital volume and to analyze if low-risk subgroups exist.
Methods and Procedures: We performed a retrospective analysis of the Nationwide Inpatient Sample from 1998-2011. Patients who underwent open or laparoscopic transhiatal and transthoracic esophageal rese
Introduction: OR time is estimated to cost $100 per minute. Despite the significant expense of this valuable resource, best practice achieves only 70% efficiency. Compounding this problem is a lack of real-time actionable date. Most current OR utilization programs require labor intensive data entry by a member of the OR team and are subject to scrutiny. Automated systems require installation and maintenance of expensive tracking hardware throughout the institution. This study developed an inexpe
Background: While the clinical benefits of minimally invasive surgery (MIS) have been proven over open surgery, the overall financial benefits are yet to be fully explored. Our goal was to evaluate the financial benefits of MIS from the payer’s perspective to demonstrate the value of minimally invasive colorectal surgery. The reduction in cost, complications, and readmissions with MIS could result in an overall benefit to the healthcare system.
Methods: A claim-based analysis using commercial